Compare Clorox Co (CLX) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Clorox Co vs Mesoblast Limited — how do they compare? Clorox Co trades at $107 (market cap $13.09B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: Clorox Co is far larger — about 5.9× Mesoblast Limited's market cap, and Clorox Co pays a 4.62% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| CLX | MESO | |
|---|---|---|
Market Cap | $13.09B | $2.21B |
Sector | Consumer Staples | Technology |
52-Week High | $127.16 | $20.96 |
52-Week Low | $86.12 | $12.88 |
Enterprise Value | $18.47B | $2.21B |
Dividend Yield | 4.62% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Clorox Co
With a history dating back more than 100 years, Clorox now plays in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just shy of 85% of Clorox's sales stem from its home turf.
Read more on CLX →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
